For indications like Parkinson's Disease that rely on subjective reporting measures, the placebo response is a major problem:

• Increased development costs
• Extended timelines
• Premature abandonment of promising development programs

Ultimately, this results in a lack of effective treatments for patients suffering from parkinson's Disease.

In this guide, we explore:

• The unique impact of the placebo problem on patients with Parkinson's Disease
• Historical methods for managing the placebo response in pain treatment
• A new strategy aimed at successfully delivering a cure